Uncover key drivers, emerging technologies, and competitive movements shaping the flowable hemostats market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Flowable Hemostats Market in 2026, and what figure is it projected to hit by 2030?
The flowable hemostats market has experienced significant expansion in recent years. It is anticipated to increase from $1.02 billion in 2025 to $1.1 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. This historical growth can be attributed to several factors including an increase in surgical procedure volumes, the growing acceptance of sophisticated surgical tools, the availability of gelatin-based hemostatic agents, the proliferation of specialized surgical disciplines, and heightened surgeon awareness regarding flowable hemostats.
The flowable hemostats market is projected to experience robust expansion over the coming years. This market is anticipated to reach $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5%. The expansion projected for this period stems from factors such as a heightened need for quicker bleeding management, an elevated emphasis on patient safety results, the proliferation of minimally invasive and robotic surgical procedures, escalating advancements in bioresorbable substances, and an increasing application in emergency and trauma medical situations. Key trends identified for the forecast timeframe encompass the expanding utilization of flowable hemostats in intricate surgical operations, an uptick in the embrace of combined hemostatic offerings, a surging requirement for prompt hemostasis methods, the broadening scope of minimally invasive surgical uses, and a heightened concentration on materials that are biocompatible.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp
Which Drivers Are Affecting Market Participation In The Flowable Hemostats Market?
The growth of the flowable hemostats market is anticipated to be spurred by a rising volume of surgical procedures moving forward. The uptick in surgical procedures is a result of an aging demographic, which boosts the requirement for age-specific operations, coupled with technological progress that has made surgeries both safer and more reachable. Flowable hemostats demonstrate significant utility in surgical settings, assisting in the management of bleeding in regions challenging to access or where conventional approaches might prove insufficient. To illustrate, a report released in June 2024 by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, stated that in 2023, the overall number of surgical and non-surgical procedures saw an increase of 3.4%, amounting to 34.9 million, when compared to the prior year. Thus, the escalating count of surgical procedures is serving as a catalyst for the expansion of the flowable hemostats market.
What Segment Categories Are Covered In The Flowable Hemostats Market?
The flowable hemostats market covered in this report is segmented –
1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats
2) By Material: Porcine Gelatin, Bovine Gelatin
3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications
4) By End User: Hospital And Clinics, Ambulatory Surgery Centers
Subsegments:
1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats
2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats
3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats
Which Trends Are Shaping Activity Within The Flowable Hemostats Market?
Leading firms within the flowable hemostats market are prioritizing the creation of cutting-edge hemostatic agents for surgery, including innovations like no-swell technology, to meet changing procedural demands. This no-swell technology denotes a characteristic of a hemostatic substance that inhibits fluid absorption and subsequent expansion, rendering it appropriate for operations where swelling might lead to issues. An example occurred in January 2023, when Medcura Inc., a US-based surgical tech company, was granted Food and Drug Administration (FDA) breakthrough device status for its LifeGel flowable technology, which manages intraoperative bleeding in cases where swelling is unacceptable. Medcura’s LifeGel stands as the sole flowable hemostatic gel specifically formulated to tackle problems related to hemostatic swelling. This absorbable agent avoids swelling because it is fully pre-hydrated and immediately usable, potentially lessening dangers linked to swelling like nerve damage and paralysis. Furthermore, it is economical, maintains antimicrobial attributes, appears relatively transparent, and adheres to tissues (mucoadheres), thus providing a more secure and efficient method for managing hemorrhage during intricate surgical operations.
Which Key Players Are Driving Competition In The Flowable Hemostats Market?
Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report
How Does The Flowable Hemostats Market Perform Across Major Global Regions?
North America was the largest region in the flowable hemostats market in 2025. The regions covered in the flowable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Flowable Hemostats Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20552&type=smp
Browse Through More Reports Similar to the Global Flowable Hemostats Market 2026, By The Business Research Company
Cyclic Heavy Menstrual Bleeding Market Report 2026
Gastrointestinal Bleeding Treatment Devices Market Report 2026
Bleeding Disorders Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model